2 completed, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
Follow Placebo (blinded): new trials by email Literature Review of Placebo (blinded) trials Research Report on Placebo (blinded)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Investigation of Vancomycin Efficacy in Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis Placebo (blinded), Vancomycin (blinded), Vancomycin (open-label extension) - Ulcerative Colitis (UC), Primary Sclerosing Cholangitis (PSC) | Phase 2 | Recruiting | McMaster University | 14 | 2026-06-17 | 2026-10-09 |
| A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) Placebo (blinded), LX9211 (blinded) - Diabetic Peripheral Neuropathic Pain | Phase 2 | Completed | Lexicon Pharmaceuticals | 496 | 2023-11-29 | 2025-10-10 |
| Dupilumab in Eosinophilic Gastritis Dupilumab (blinded), Placebo (blinded) - Eosinophilic Gastritis, Eosinophilic Gastroenteritis | Phase 2 | Completed | Children's Hospital Medical Center, Cincinnati | 41 | 2021-05-15 | 2025-11-04 |
Cholangitis, Sclerosing (1) · Colitis, Ulcerative (1) · Eosinophilic enteropathy (1)
Children's Hospital Medical Center, Cincinnati (1) · Lexicon Pharmaceuticals (1) · McMaster University (1)
United States (2) · Canada (1)
Marc Rothenberg (1) · Neeraj Narula, MD (1)
U54AI117804 (1)